The speed at which several COVID-19 vaccines went from conception to receiving FDA and
EMA approval for emergency use is an achievement unrivaled in the history of vaccine …

FDA-approved and emergency use-authorized vaccines using new mRNA and viral-vector
technology are highly effective in preventing moderate to severe disease; however, …

Although two vaccines for Zaire ebolavirus (EBOV) have been licensed and deployed
successfully to combat recurring outbreaks of Ebolavirus Disease in West Africa, there are no …

The Ebola virus has caused outbreaks in Central and West Africa, with high rates of morbidity
and mortality. Clinical trials of recombinant virally vectored vaccines did not explicitly …

Ebola virus (EBOV) causes lethal hemorrhagic fevers with case fatality rates of up to 90%.
The recent large outbreak in West Africa and current outbreak in the DRC demonstrate an …

… to the University of Liberia Fendall Laboratory within 24 h to be stored until further analysis.
… well in a volume of 50 μL and incubated for 2 h on a plate shaker set at 700 rpm in a dark …

Ebola virus (EBOV) causes lethal hemorrhagic fevers with case fatality rates of up to 90%.
Outbreaks are sporadic and unpredictable, and vaccination has been key to controlling …

The use of bibliometrics to analyze academic productivity has gained increasing attention in
the surgical community. 1, 2 Citation count is the most used publication-level metric that …

Objective: The aim of this study was to compare mortality following emergency laparotomy
between populations from New York State and England. Summary of Background Data: …

This study examined a thematic network aimed at identifying experiences that influence
patients’ outcomes (eg, patients’ satisfaction, anxiety, and discharge readiness) in an effort to …